Evidence map›Paper›PMID 31384277›Full record

ArticleRevista panamericana de salud publica = Pan American journal of public health2017

Strengthening and implementing health technology assessment and the decision-making process in the Region of the Americas.

Fernanda Lessa, Francisco Caccavo, Stephanie Curtis, Stéphanie Ouimet-Rathé, Alexandre Lemgruber

Abstract read
In one paragraph

Article in Revista panamericana de salud publica = Pan American journal of public health, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Hospital-based health technology assessment (HTA) in Latin America and the Caribbean: a scoping review.Revista panamericana de salud publica = Pan American journal of public health · 2025
    Review
  11. Article
  12. Article
  13. Article
  14. Expectations for the Development of Health Technology Assessment in Brazil.International journal of environmental research and public health · 2021
    Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Fernanda LessaMedicines and Health Technologies Unit Pan American Health Organization/World Health Organization Washington, D.C. United States of America Medicines and Health Technologies Unit, Pan American Health Organization/World Health Organization, Washington, D.C., United States of America.
Francisco CaccavoMedicines and Health Technologies Unit Pan American Health Organization/World Health Organization Washington, D.C. United States of America Medicines and Health Technologies Unit, Pan American Health Organization/World Health Organization, Washington, D.C., United States of America.
Stephanie CurtisMedicines and Health Technologies Unit Pan American Health Organization/World Health Organization Washington, D.C. United States of America Medicines and Health Technologies Unit, Pan American Health Organization/World Health Organization, Washington, D.C., United States of America.
Stéphanie Ouimet-RathéMedicines and Health Technologies Unit Pan American Health Organization/World Health Organization Washington, D.C. United States of America Medicines and Health Technologies Unit, Pan American Health Organization/World Health Organization, Washington, D.C., United States of America.
Alexandre LemgruberMedicines and Health Technologies Unit Pan American Health Organization/World Health Organization Washington, D.C. United States of America Medicines and Health Technologies Unit, Pan American Health Organization/World Health Organization, Washington, D.C., United States of America.

Funding

World Health Organization 001
6 · The paper itself

Abstract

objectiveHealth technology assessment (HTA) has been adopted by countries in order to improve allocative efficiency in their health systems. This study aimed to describe and analyze the HTA decision-making process in the Region of the Americas.

methodsA literature review was done to better understand the HTA situation in the Region. Also, in 2014 and 2015, individuals responsible for conducting HTA in countries of the Americas were identified and received a questionnaire on HTA and the decision-making process.

resultsA total of 46 questionnaire responses were obtained, from 30 countries. The respondents were similar in terms of their institutions, main funding sources, and technology types assessed. Of the 46 respondents, 23 (50%) work for their respective ministry of health. Also, 36 (78%) undertake and/or coordinate HTA through coverage and reimbursement/pricing decisions and other HTA-related activities, while 24 (52%) use HTA for emerging technologies. While some countries in the Region have created formal HTA units, there is a weak link between the HTA process and decision-making. Most of the countries with recognized HTA institutions are members of the Health Technology Assessment Network of the Americas (RedETSA). Despite the advances in the Region overall, most countries in Central America and the Caribbean are still at the early stages of implementing HTA to support decision-making.

conclusionsMany countries in the Americas have benefited from the exchange and capacity-building opportunities within RedETSA. However, there are still many challenges to overcome in the Region in terms of the discussion and creation of HTA-related policies.

Indexed as

Americasbiomedicaldecision makinghealth economicshealth prioritieshealth systemsTechnology assessment

Identifiers

PMID31384277
PMCPMC6650625

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.